Genomic Vision Aktie [WKN DE: A110TM / ISIN: FR0011799907]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Genomic Vision SA

09.01.18		Genomic Vision: 2018 Financial Calendar (Businesswire)
19.12.17		Genomic Vision Optimizes the Terms of Its OCABSA (Convertible Notes with Warrants) Financing Line to Obtain Greater Flexibility within the Framework of Its Development (Businesswire)
24.10.17		Genomic Vision: Revenue from Sales for the First 9 Months of 2017 up 103% to €1.3 Million (Businesswire)
19.10.17		Genomic Vision Signs a Distribution Agreement with AmCare Genomics Laboratory in China for Its FSHD Diagnostic Assay (Businesswire)
18.10.17		Genomic Vision: Report of the LSR R&D Day (Businesswire)
11.10.17		Genomic Vision Presented the Interim Results of Its Clinical Trial in Cervical Cancer Screening at the Eurogin Annual Congress (Businesswire)
11.09.17		Genomic Vision: High Attendance at the 1st US Satellite Symposium on Molecular Combing (Businesswire)
27.07.17		Genomic Vision: Molecular Combing Featured in an Oral Presentation on CRISPR/Cas9 Gene Editing at the 3rd CSHL Meeting in New York (Businesswire)
25.07.17		Genomic Vision: First half 2017 results (Businesswire)
10.05.17		Genomic Vision Announces Promising Preliminary Results for Its Clinical Study in Cervical Cancer Detection in the Czech Republic (Businesswire)
28.10.16		Genomic Vision: Financial Information at September 30th, 2016 (Businesswire)
20.10.16		Genomic Vision Presents the Initial Results of the Pilot Study Undertaken with Quest Diagnostics in Spinal Muscular Atrophy (SMA) at the ASHG 2016 Annual Meeting in Vancouver (Businesswire)
26.07.16		Genomic Vision: Results for the First Half of 2016 (Businesswire)
20.07.16		Genomic Vision is Accelerating Its Clinical Trial in Cervical Cancer with an Additional Study in the Czech Republic (Businesswire)
20.07.16		Genomic Vision is Accelerating Its Clinical Trial in Cervical Cancer with an Additional Study in the Czech Republic (Businesswire)
11.07.16		Genomic Vision Launches EasyScan, the First Digital Service for Analyzing DNA by Molecular Combing (Businesswire)
09.05.16		Genomic Vision: Financial Information at March 31, 2016 (Businesswire)
23.03.16		Genomic Vision: New Strategic Development Area (Businesswire)
22.03.16		Genomic Vision: 2015 Annual Results (Businesswire)
17.03.16		Genomic Vision Obtains NF EN ISO 13485:2012 Quality Certification (Businesswire)
10.03.16		Genomic Vision’s DNA Analysis Technology Singled out in a Study Published by Nature (Businesswire)
08.02.16		Genomic Vision to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference (Businesswire)
04.02.16		Genomic Vision: 2016 Financial Calendar (Businesswire)
18.01.16		Genomic Vision: 2015 Sales in Line with Expectations after All Planned Milestones with Quest Diagnostics Were Met (Businesswire)
14.01.16		Genomic Vision to demonstrate 'molecular combing' technology's ability to identify novel cancer-causing BRCA gene variants (Businesswire)
11.01.16		Genomic Vision Expands its Senior Management Team through a Number of Strategic Recruitments (Businesswire)
14.12.15		Genomic Vision and Reims University Hospital Launch Clinical Study to Establish New Screening Tool for Early Detection and Prevention of Cervical Cancer (Businesswire)
03.12.15		Genomic Vision Signs a Strategic Partnership with the Imagine Institute, Europe’s Largest Genetic Research and Care Cluster (Businesswire)
01.12.15		Genomic Vision to Present at the LD Micro Main Event (Businesswire)
12.11.15		GENOMIC VISION to Present at the Canaccord Genuity 2015 Medical Technology & Diagnostics Forum (Businesswire)
22.10.15		Genomic Vision: Financial Information at September 30, 2015 (Businesswire)
15.10.15		Genomic Vision and Rouen University Hospital Launch Genomic Biomarker Identification Trial to Improve Genetic Counseling for Infantile Spinal Muscular Atrophy in France (Businesswire)
31.07.15		Genomic Vision: 2015 First-Half Results in Line with Company Expectations (Businesswire)
09.06.15		Genomic Vision Selected for the Horizon 2020 Program’s ‘BeyondSeq’ Project with a Total Grant of €6 Million (Businesswire)
06.05.15		Genomic Vision: Financial information at March 31, 2015 (Businesswire)
10.03.15		Genomic Vision : 2014 Annual Results in Line with the Company’s Buoyant Development (Businesswire)
17.02.15		Genomic Vision Renews Its Strategic Collaboration with Quest Diagnostics for Three More Years (Businesswire)
17.02.15		Genomic Vision Renews Its Strategic Collaboration with Quest Diagnostics for Three More Years (Businesswire)
09.02.15		Genomic Vision : 2015 Financial Agenda (Businesswire)
15.01.15		Genomic Vision: 2014 Annual Revenue from Sales at €3.5 Million (Businesswire)
07.01.15		Genomic Vision Achieves Major Milestone with Delivery of New High-Throughput Genome Analyzer to Quest Diagnostics (Businesswire)
07.01.15		Genomic Vision Achieves Major Milestone with Delivery of New High-Throughput Genome Analyzer to Quest Diagnostics (Businesswire)
24.11.14		Genomic Vision Appoints David Del Bourgo as Head of Sales and Marketing (Businesswire)
17.11.14		Genomic Vision Chosen for the New EnterNext© PEA-PME 150 Index (Businesswire)
14.10.14		Genomic Vision Strengthens Its Intellectual Property (Businesswire)
09.10.14		Genomic Vision : Financial Information as of September 30, 2014 (Businesswire)
11.09.14		Genomic Vision strengthens its management team (Businesswire)
08.09.14		Genomic Vision Joins the CAC® Mid & Small Index (Businesswire)
25.08.14		Genomic Vision Has Presented the First Results of Its HPV Detection Test at the HPV 2014 Conference in Seattle (Businesswire)
28.07.14		Genomic Vision: 2014 first-half results in line with company expectations (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Pierer-Aktie letztlich zweistellig höher: KTM ist insolvent - Antrag auf Sanierung in Eigenverwaltung

Solana Kurs Prognose: 300 US-Dollar noch in diesem Jahr?

Pierer Mobility-Aktie unter Druck: KTM-Pleite - Schockstarre in der Region und bei den Zulieferern - Land OÖ signalisiert Bereitschaft Beschäftigten zu helfen

voestalpine-Aktie zieht an: Erste Group stuft Aktie von "Accumulate" auf "Buy" hoch

Rosenbauer erwartet kein Problem bei Kapitalerhöhung wegen KTM-Pleite - Rosenbauer-Aktie fester

Pierer Mobility-Aktie bricht ein: KTM steht vor Insolvenz

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	30.11.2024 22:33
Kaufwert:	EUR
	Hinzufügen Speichern